BioSpace News Archive

Drs. Emily Mackler and Evelyn Handel will give keynote speeches at the conferences

Sage Therapeutics, Inc. announced that on October 1, 2019, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 8,100 shares of its common stock, and 1,350 performance restricted stock units to four new employees under Sage’s 2016 Inducement Equity Plan.

Frequency Therapeutics, Inc. announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $14.00 per share, for total gross proceeds of approximately $84.0 million, before deducting underwriting discounts and commissions.

Alfa Chemistry, a well known New York-based chemical supplier, announced to enlarge its product lines by offering a wide range of surfactant products to their customers.

Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will connect with local industry leaders and share insights and expertise at the local conference of the Association of Clinical Research Professionals, ACRP, taking place on October 3-4 in Research Triangle Park.

On 15 October, Lonza will host a free 60-minute webinar that will address current concerns regarding the use of serum in cell culture media, explore viable alternatives and provide guidance on how to adapt cells to a serum-free environment.

Brian Carwile transitions to chairman of the board; Paul Taylor named as president & CEO; David Anderson named as COO